Top EU Regulator Attacks Complexity & Duplication In European System
Long Approval Times In The Spotlight At DIA Europe
Industry and agency speakers at the DIA Europe 2022 conference voiced a litany of complaints about the EU’s drug regulatory framework, saying it has failed to keep up with developments in science and that too much assessment work is being duplicated.
